Molecular mechanism of multi-drug resistance in Shigella isolates from rural China

S Mehata1, G C Duan

  • 1Department of Epidemiology, College of Public Health, Zhengzou University, Henan, China.

Insights

Shigella infections show high resistance to common antibiotics like amoxicillin-clavulanate and nalidixic acid. While mutations in the marA gene were observed, they appear to play a minor role in the overall antimicrobial resistance of Shigella.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Diarrhoeal diseases and enteric infections are significant causes of illness and death in developing nations.
  • Shigellosis ranks as a major infectious disease contributor to mortality in China.

Purpose of the Study:

  • To investigate antimicrobial susceptibility patterns in Shigella isolates.
  • To identify mutations in the marA gene and assess their association with drug resistance in Shigella.

Main Methods:

  • Antimicrobial susceptibility testing was performed on 100 Shigella isolates.
  • Polymerase Chain Reaction-Single Strand Conformation Polymorphism (PCR-SSCP) was used to detect marA gene mutations.

Main Results:

  • High resistance rates were observed for amoxicillin-clavulanate (85%), nalidixic acid (100%), and piperacillin (100%).
  • Shigella flexneri exhibited greater resistance to amoxicillin-clavulanate and ciprofloxacin compared to Shigella sonnei.
  • A 19% mutation rate was found in the marA gene, with specific mutations identified at codons 6, 319, and 374.

Conclusions:

  • Shigella isolates display considerable antimicrobial resistance, particularly to amoxicillin-clavulanate and nalidixic acid.
  • Mutations in the marA gene may contribute to drug resistance in Shigella, but likely play a secondary role to other resistance mechanisms.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...